NCT06519422View on ClinicalTrials.gov

Tranexamic Acid for Anaemia Trial

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

September 30, 2028

Conditions
Anemia
Interventions
DRUG

Tranexamic Acid 500 MG

Tablets

OTHER

Matched placebo

Matched placebo tablets (inactive ingredients only, including microcrystalline cellulose, magnesium stearate BP and lactose)

All Listed Sponsors
collaborator

The Jon Moulton Charity Trust

UNKNOWN

lead

London School of Hygiene and Tropical Medicine

OTHER